Educational Symposium during the ISPOR 14th Annual International Meeting
The Comparative Effectiveness Research Wave: Solving Surfing Techniques
Monday, May 18, 2009
7:15AM-8:15AM
Sponsored by UBC

Symposia are free and open to all ISPOR delegates, no pre-registration required.
Whether we like it or not, the new evidence ‘wave’ includes comparative trials and with it comes the need to solve new ‘surfing’ techniques. The future comparative effectiveness (CE) research agenda inevitably will (and should!) include comparative real world (aka “pragmatic”) trials. Traditional research designs are extremely expensive and lengthy making them not very practical. Further, there tends to be high uncertainty due to the nature of the messy real world. This session poses a Bayesian adaptive design approach as a possible solution to reduce uncertainty of findings, cost and time and features a series of working papers to address four specific technical issues:
Moderator: Bryan R. Luce PhD, MBA, Senior Vice President, Science Policy, United BioSource Corporation, Bethesda, MD, USA
Getting to “Yes” (aka: When do we know (what is the minimal threshold) when we have “just enough” evidence for a real world (read, coverage decision maker; clinical guideline committee) decision?
Speaker: Bryan R. Luce, PhD, MBA, Senior Vice President, Science Policy, United BioSource Corporation, Bethesda, MD, USA
Thresholds to Invest: Manufacturers’ Elasticities for Sponsoring Real World Comparative Trials (aka: Just how much does cost, time, risk need to be decreased for a manufacturer to fund a CE trial of its product?)
Speaker: Anirban Basu PhD, Asst. Professor, Hospital Medicine, Dept of Medicine, University of Chicago, Chicago, IL, USA
Building off the Existing Evidence (aka: The world may be flat, but is the prior?)
Speaker: David J. Vanness PhD, Research Scientist, United BioSource Corporation, Bethesda, MD, USA
The Role of Dynamic Predictive Simulation in Guiding the Pragmatic, Adaptive Trial
Speaker: J. Jaime Caro MDCM, FRCPC, FACP, Senior Vice President & Senior Research Scientist, Health Economics, United BioSource Corporation, Lexington, MA, USA
Educational Symposium during the ISPOR 14th Annual International Meeting
Monday, May 18, 2009
1:15PM-2:15PM
Sponsored by IMS
Striving Towards a New Value Equation: The Need to Integrate Pricing & Reimbursement and Health Economics & Outcomes Research to Support Various Stakeholders in
Improving Health Care Systems
Symposia are free and open to all ISPOR delegates, no pre-registration required.
This symposium will outline the need to integrate pricing and reimbursement (P&R) and health economics and outcomes research (HEOR) to meet changing requirements and market complexities. A new value equation will be defined, now involving multiple stakeholders who are charged with reforming our health care systems - not just payers, but governmental and influential NGOs, as well as many emerging public-private partnerships lobbying on behalf of taxpayers and patients. Potential ways towards achieving the new value equation will be outlined.
| 1:15PM-1:20PM |
INTRODUCTION |
| |
Moderator: Jonothan Tierce CPhil, General Manager and Center of Excellence Leader Global Health Economics & Outcomes Research, IMS Health, Falls Church VA, USA |
| 1:20PM-1:40PM |
EVOLVING PRICING STRATEGIES IN A MULTI-STAKEHOLDER, EVIDENCE-BASED ENVIRONMENT |
| |
Speaker: Frederic King MBA, Pricing and Market Access Director, Global Marketing, AstraZeneca, Wilmington, DE, USA |
| 1:40PM-2:00PM |
OPPORTUNITIES FOR HEOR TO ASSIST IN COMMERCIAL DECISION MAKING IN THE NEW ENVRIONMENT |
| |
Speaker: David S. Battleman MD, MSc, MBA, Senior Principal, Health Economics and Outcomes Research, IMS Health, Falls Church, VA, USA |
| 2:00PM-2:15PM |
DISCUSSION/Q & A |
|
|
14th Annual International Meeting Main Page
|